US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist
  • 8.250
  • -0.100-1.20%
Close Dec 27 16:00 ET
  • 8.250
  • 0.0000.00%
Post 16:00 ET
582.18MMarket Cap-4.53P/E (TTM)

Oric Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-46.59%-28.8M
-21.19%-25.63M
-46.34%-30.19M
-14.03%-85.69M
-58.33%-24.27M
-1.68%-19.65M
-18.95%-21.15M
9.20%-20.63M
-26.20%-75.14M
5.86%-15.33M
Net income from continuing operations
-35.67%-34.57M
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
Operating gains losses
----
----
----
-45.00%22K
--13K
--0
----
----
1,900.00%40K
----
Depreciation and amortization
5.06%270K
5.02%272K
3.16%261K
6.83%1.03M
6.48%263K
16.29%257K
4.86%259K
0.80%253K
7.69%966K
7.86%247K
Change In working capital
-34.26%2.39M
426.48%3.37M
-2,726.05%-8.17M
1,200.67%4.9M
-27.09%1.98M
53.66%3.63M
40.54%-1.03M
108.19%311K
-110.93%-445K
4.21%2.72M
-Change in prepaid assets
689.17%1.63M
-105.69%-434K
-318.40%-2.41M
57.28%1.62M
-21.30%1.01M
-114.85%-277K
86.61%-211K
305.78%1.1M
-9.81%1.03M
867.42%1.28M
-Change in payables and accrued expense
-80.64%757K
563.41%3.8M
-627.02%-5.76M
322.24%3.28M
-32.20%979K
682.20%3.91M
-418.99%-820K
75.71%-792K
-150.32%-1.48M
-41.75%1.44M
Cash from discontinued investing activities
Operating cash flow
-46.59%-28.8M
-21.19%-25.63M
-46.34%-30.19M
-14.03%-85.69M
-58.33%-24.27M
-1.68%-19.65M
-18.95%-21.15M
9.20%-20.63M
-26.20%-75.14M
5.86%-15.33M
Investing cash flow
Cash flow from continuing investing activities
139.89%23.07M
194.65%18.28M
-584.18%-61.87M
60.27%-43.4M
-25.93%20.96M
-8,342.48%-57.83M
58.20%-19.31M
114.09%12.78M
-168.95%-109.25M
7,962.68%28.3M
Net PPE purchase and sale
-442.86%-418K
17.78%-333K
29.68%-218K
59.14%-849K
80.14%-57K
80.80%-77K
39.28%-405K
57.12%-310K
-121.30%-2.08M
26.22%-287K
Net investment purchase and sale
140.67%23.49M
198.44%18.61M
-571.04%-61.65M
60.29%-42.55M
-26.47%21.02M
-20,235.92%-57.75M
58.48%-18.91M
114.55%13.09M
-167.24%-107.17M
3,763.11%28.59M
Cash from discontinued investing activities
Investing cash flow
139.89%23.07M
194.65%18.28M
-584.18%-61.87M
60.27%-43.4M
-25.93%20.96M
-8,342.48%-57.83M
58.20%-19.31M
114.09%12.78M
-168.95%-109.25M
7,962.68%28.3M
Financing cash flow
Cash flow from continuing financing activities
306.45%126K
-99.04%816K
125.03M
239.58%85.66M
-98.17%453K
3,000.00%31K
20,423.86%85.17M
0
-48.66%25.23M
2,949.57%24.79M
Net common stock issuance
--0
--0
--125M
240.00%85M
--0
--0
--85M
--0
-50.00%25M
--25M
Proceeds from stock option exercised by employees
306.45%126K
104.00%816K
--198K
41.83%885K
136.46%454K
3,000.00%31K
-3.61%400K
--0
-36.71%624K
-76.38%192K
Net other financing activities
--0
--0
---168K
43.11%-227K
---1K
--0
----
----
78.46%-399K
----
Cash from discontinued financing activities
Financing cash flow
306.45%126K
-99.04%816K
--125.03M
239.58%85.66M
-98.17%453K
3,000.00%31K
20,423.86%85.17M
--0
-48.66%25.23M
2,949.57%24.79M
Net cash flow
Beginning cash position
-51.69%50.32M
-4.38%56.85M
-64.53%23.88M
-70.28%67.31M
-9.53%26.73M
110.25%104.17M
-47.43%59.46M
-70.28%67.31M
188.70%226.47M
-87.77%29.54M
Current changes in cash
92.77%-5.6M
-114.60%-6.53M
520.08%32.98M
72.71%-43.43M
-107.56%-2.85M
-287.15%-77.45M
170.35%44.72M
93.08%-7.85M
-207.52%-159.17M
349.76%37.76M
End cash Position
67.31%44.72M
-51.69%50.32M
-4.38%56.85M
-64.53%23.88M
-64.53%23.88M
-9.53%26.73M
110.25%104.17M
-47.43%59.46M
-70.28%67.31M
-70.28%67.31M
Free cash flow
-48.13%-29.22M
-20.45%-25.96M
-45.21%-30.4M
-12.06%-86.54M
-55.78%-24.33M
-0.01%-19.72M
-16.85%-21.55M
10.68%-20.94M
-27.68%-77.22M
6.34%-15.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -46.59%-28.8M-21.19%-25.63M-46.34%-30.19M-14.03%-85.69M-58.33%-24.27M-1.68%-19.65M-18.95%-21.15M9.20%-20.63M-26.20%-75.14M5.86%-15.33M
Net income from continuing operations -35.67%-34.57M-39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M
Operating gains losses -------------45.00%22K--13K--0--------1,900.00%40K----
Depreciation and amortization 5.06%270K5.02%272K3.16%261K6.83%1.03M6.48%263K16.29%257K4.86%259K0.80%253K7.69%966K7.86%247K
Change In working capital -34.26%2.39M426.48%3.37M-2,726.05%-8.17M1,200.67%4.9M-27.09%1.98M53.66%3.63M40.54%-1.03M108.19%311K-110.93%-445K4.21%2.72M
-Change in prepaid assets 689.17%1.63M-105.69%-434K-318.40%-2.41M57.28%1.62M-21.30%1.01M-114.85%-277K86.61%-211K305.78%1.1M-9.81%1.03M867.42%1.28M
-Change in payables and accrued expense -80.64%757K563.41%3.8M-627.02%-5.76M322.24%3.28M-32.20%979K682.20%3.91M-418.99%-820K75.71%-792K-150.32%-1.48M-41.75%1.44M
Cash from discontinued investing activities
Operating cash flow -46.59%-28.8M-21.19%-25.63M-46.34%-30.19M-14.03%-85.69M-58.33%-24.27M-1.68%-19.65M-18.95%-21.15M9.20%-20.63M-26.20%-75.14M5.86%-15.33M
Investing cash flow
Cash flow from continuing investing activities 139.89%23.07M194.65%18.28M-584.18%-61.87M60.27%-43.4M-25.93%20.96M-8,342.48%-57.83M58.20%-19.31M114.09%12.78M-168.95%-109.25M7,962.68%28.3M
Net PPE purchase and sale -442.86%-418K17.78%-333K29.68%-218K59.14%-849K80.14%-57K80.80%-77K39.28%-405K57.12%-310K-121.30%-2.08M26.22%-287K
Net investment purchase and sale 140.67%23.49M198.44%18.61M-571.04%-61.65M60.29%-42.55M-26.47%21.02M-20,235.92%-57.75M58.48%-18.91M114.55%13.09M-167.24%-107.17M3,763.11%28.59M
Cash from discontinued investing activities
Investing cash flow 139.89%23.07M194.65%18.28M-584.18%-61.87M60.27%-43.4M-25.93%20.96M-8,342.48%-57.83M58.20%-19.31M114.09%12.78M-168.95%-109.25M7,962.68%28.3M
Financing cash flow
Cash flow from continuing financing activities 306.45%126K-99.04%816K125.03M239.58%85.66M-98.17%453K3,000.00%31K20,423.86%85.17M0-48.66%25.23M2,949.57%24.79M
Net common stock issuance --0--0--125M240.00%85M--0--0--85M--0-50.00%25M--25M
Proceeds from stock option exercised by employees 306.45%126K104.00%816K--198K41.83%885K136.46%454K3,000.00%31K-3.61%400K--0-36.71%624K-76.38%192K
Net other financing activities --0--0---168K43.11%-227K---1K--0--------78.46%-399K----
Cash from discontinued financing activities
Financing cash flow 306.45%126K-99.04%816K--125.03M239.58%85.66M-98.17%453K3,000.00%31K20,423.86%85.17M--0-48.66%25.23M2,949.57%24.79M
Net cash flow
Beginning cash position -51.69%50.32M-4.38%56.85M-64.53%23.88M-70.28%67.31M-9.53%26.73M110.25%104.17M-47.43%59.46M-70.28%67.31M188.70%226.47M-87.77%29.54M
Current changes in cash 92.77%-5.6M-114.60%-6.53M520.08%32.98M72.71%-43.43M-107.56%-2.85M-287.15%-77.45M170.35%44.72M93.08%-7.85M-207.52%-159.17M349.76%37.76M
End cash Position 67.31%44.72M-51.69%50.32M-4.38%56.85M-64.53%23.88M-64.53%23.88M-9.53%26.73M110.25%104.17M-47.43%59.46M-70.28%67.31M-70.28%67.31M
Free cash flow -48.13%-29.22M-20.45%-25.96M-45.21%-30.4M-12.06%-86.54M-55.78%-24.33M-0.01%-19.72M-16.85%-21.55M10.68%-20.94M-27.68%-77.22M6.34%-15.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data